NL-OMON55991招募中不适用
Pancreatic cancer: validation of circulating predictive biomarkers - PANCAKE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Experimental group
- •Age >= 18 years.
- •Diagnosed with (borderline) resectable, locally advanced or metastatic PDAC.
- •Treatment with FOLFIRINOX chemotherapy, including neoadjuvant therapy.
- •Written informed consent (either for PANCAKE in case of locally advanced PDAC
- •and metastasized PDAC or for the PREOPANC-2/PREOPANC-3 trial in case of
- •(borderline) resectable PDAC).
- •Control group
- •Age >= 18 years.
- •Diagnosed with (borderline) resectable, locally advanced or metastatic PDAC.
- •Treatment with gemcitabine, with or without nab-paclitaxel, chemotherapy,
- •including neoadjuvant therapy.
- •Written informed consent (either for PANCAKE in case of locally advanced PDAC
- •and metastasized PDAC or for the PREOPANC-2 trial in case of (borderline)
- •resectable PDAC).
排除标准
- •Experimental group
- •Combined treatment with other chemotherapeutics then FOLFIRINOX.
- •Previous treatment with FOLFIRINOX chemotherapy.
- •Pregnancy.
- •Serious concomitant systemic disorders that would compromise the safety of
- •the patient or his/her ability to complete the study, at the discretion of the
- •investigator.
- •Control group
- •Combined treatment with other chemotherapeutics then gemcitabine and
- •nab-paclitaxel.
- •Previous treatment with FOLFIRINOX or gemcitabine-based chemotherapy.
- •Pregnancy.
- •Serious concomitant systemic disorders that would compromise the safety of
- •the patient or his/her ability to complete the study, at the discretion of the
- •investigator.
研究者
相似试验
招募中
不适用
Validatie van predictieve biomarkers voor FOLFIRINOX respons in patiënten met pancreascarcinoomPancreatic cancerNL-OMON21925Erasmus University Medical Center, department of Surgery240
已完成
不适用
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic CancerPancreatic CancerNCT01876069Samsung Medical Center65
已完成
不适用
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic TumorsPancreatic TumorNCT01692873Institut Paoli-Calmettes274
进行中（未招募）
不适用
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid BiopsyPancreas AdenocarcinomaNCT04241367National Cancer Center, Korea420
已完成
不适用
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving ChemotherapyPancreatic CancerNCT04281511National Cancer Center, Korea238